Glenmede Trust Company »

Axsome Therapeutics shares owned by Glenmede Trust Company

Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Glenmede Trust Company from 13F filings

Historical chart of Glenmede Trust Company investment in Axsome Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Axsome Therapeutics held by Glenmede Trust Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axsome Therapeutics by Glenmede Trust Company

Quarter filed Position value Share count Share price at filing
2023-09-30 $573k 8.2k 69.89
2023-06-30 $257k 4.2k 61.68
2023-03-31 $257k 4.2k 61.68
2022-12-31 $506k 6.6k 77.13
2022-09-30 $694k 16k 44.60
2022-06-30 $217k 5.7k 38.17
2021-12-31 $209k 5.5k 37.76
2021-06-30 $371k 5.5k 67.45
2021-03-31 $324k 5.7k 56.50
2020-12-31 $462k 5.7k 81.41
2020-09-30 $364k 5.1k 71.19
2020-06-30 $216k 2.6k 82.04
2020-03-31 $527k 5.1k 103.21
2019-12-31 $527k 5.1k 103.21
2019-09-30 $121k 6.0k 20.15
2019-06-30 $89k 3.5k 25.72